This country profile provides an overview of Liberia’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage increased from 68% in 2018 to 84% in 2019.
Liberia does not require mass treatment for blinding trachoma.
Treatment coverage increased from 76% in 2018 to 93% in 2019.
Treatment coverage decreased from 97% in 2018 to 89% in 2019.
Treatment coverage increased from 69% in 2018 to 84% in 2019.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Liberia.